Joel Dudley, PhD, an internationally recognized investigator in translational bioinformatics and precision medicine, has been named Executive Vice President for Precision Health for the Mount Sinai Health System. In this new role, he will create a Precision Health Enterprise by linking pioneering research conducted in the Icahn School of Medicine at Mount Sinai (ISMMS) with implementation strategies developed in collaboration with leadership and staff throughout the Health System.Precision
Read More
Boston Children’s Hospital Powers Pediatric Patients with Virtual Reality to Visualize Their Insides
Boston Children’s Hospital and Klick Health, today unveiled a virtual reality (VR) platform to bring patients’ individual medical findings to life in an immersive, 3D environment. The proof of concept VR platform named HealthVoyager is a medical education and patient experience platform. The first iteration of the tool, HealthVoyager™ GI, has been designed for pediatric gastrointestinal (GI) patients and is being used at Boston Children’s as part of a clinical study to validate its effect on
Read More
Cota Lands $40M to Accelerate Value-based Precision Medicine
Cota, a NYC-based healthcare data and analytics company bridging precision medicine to population health has raised $40 million in Series C funding led by QVIA and was contributed to by EW Healthcare Partners. Memorial Sloan Kettering Cancer Center also participated in the round, along with existing Cota investors which include, Boston Millennia Partners, Horizon Blue Cross Blue Shield of New Jersey, Hackensack Meridian Health and Atoc Holdings.The funding will go towards rapidly scaling its
Read More
Cedars-Sinai, Emulate Partner on ‘Patient-on-a-Chip’ Program to Predict Disease Treatments
Scientists at Cedars-Sinai and Boston-based digital health startup Emulate are pioneering a Patient-on-a-Chip program to help predict which disease treatments would be most effective based on a patient's genetic makeup and disease variant—a new approach to advance precision medicine.Researchers know that people respond differently to foods, drugs, and chemicals. For example, a medication may be effective in one individual, while it makes another even more ill. Until now, we’ve had no way to test
Read More
Orion Health Launches Rhapsody Integration Engine on Amazon Cloud
Orion Health, a provider of interoperability, population health management, and precision medicine solutions, today announced the global launch of Rhapsody as a Service (RaaS), a cloud-based integration solution, powered by Amazon Web Services (AWS).Offering a full-service model to healthcare organizations, Orion Health also announces RaaS’s global Integration as a Service (IaaS) capability to manage and maintain the entire integration engine for customers.Orion Health’s Rhapsody Integration
Read More
Engine Biosciences Lands $10M for AI-Driven Drug Discovery Platform
Engine Biosciences("Engine"), a San Francisco, CA-based biotech company pioneering its artificial intelligence and genomics network biomedicine platform for drug discovery has raised $10 million. The seed round was co-led by by DHVC (Danhua Capital) and 6 Dimensions Capital, with participation from global biopharmaceutical leader WuXi AppTec, EDBI, Pavilion Capital, Baidu Ventures, WI Harper, and Nest.Bio Ventures.The company plans to utilize the funding to support its proprietary platform,
Read More
Medidata, Syapse Partner to Democratize Access to Oncology Clinical Trials
Medidata, a provider of cloud-based technology and data analytics for clinical research, and Syapse, a precision medicine solutions provider, have announced a new partnership to transform oncology clinical trials for the age of precision medicine. As part of the new partnership, Medidata and Syapse will jointly develop a portfolio of solutions to make it easier for cancer patients to access potentially life-saving clinical trials,Partnership DetailsThe partnership will initially build products
Read More
Syapse Expands Precision Medicine to Asia Through Partnership With Health System
Syapse, a precision medicine company, announced today it is expanding to Asia through new partnerships with Seoul National University Hospital (SNUH), the premier hospital in Korea, and Megazone, a cloud-specialized IT company.Syapse and SNUH are launching a precision oncology program to improve cancer care in Korea, with the support of Megazone’s innovative cloud services. SNUH, one of the largest health systems in South Korea, is the first health system outside the U.S. to use the Syapse
Read More
Why Did the Global Digital Health Market Strengthen During Q4 2017?
Healthcare innovation consultancy Enspektos, LLC, today released the latest edition of its quarterly study, digihealth impact trac. The report focuses on key Q4 2017 market themes and previews five digital health trends that will matter in 2018. The research reveals that telemedicine is having a far-reaching impact as adoption surges globally. Most importantly, telemedicine solutions are delivering economic benefits and re-shaping the patient-physician relationship, as clinicians learn what it
Read More
Cota Partners with Miami Cancer Institute to Fuel Personalized Cancer Treatment
Cota, a healthcare data and analytics company bridging precision medicine to population health has announced their latest collaboration with Baptist Health South Florida to advance cancer treatment and clinical research at the new Miami Cancer Institute (MCI). The partnership will further support the organization’s initiative of precision medicine, improve care delivery and ensure the most effective treatment for every type of cancer.MCI will leverage Cota’s Provider Solution to identify
Read More